Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4101
CALL
Zillow
Z
$6.13B
| $832K | ﹤0.01% |
24,700
-41,300
| -63% | -$1.47M |
2015 Q3
6 quarters
|
|
|
RDS.B
4102
CALL
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $832K | ﹤0.01% |
14,900
-6,200
| -29% | -$352K |
2016 Q2
3 quarters
|
|
4103
CALL
Restaurant Brands International
QSR
$24.2B
| $831K | ﹤0.01% |
14,900
-11,400
| -43% | -$597K |
2014 Q4
9 quarters
|
|
|
DNB
4104
PUT
DELISTED
Dun & Bradstreet
DNB
| $831K | ﹤0.01% |
7,700
-1,200
| -13% | -$136K |
2014 Q2
11 quarters
|
|
|
XCRA
4105
DELISTED
Xcerra Corporation
XCRA
| $831K | ﹤0.01% |
93,463
+19,451
| +26% | +$160K |
2016 Q2
3 quarters
|
|
4106
CALL
SolarEdge
SEDG
$2.04B
| $830K | ﹤0.01% |
53,200
-16,200
| -23% | -$225K |
2015 Q2
7 quarters
|
|
4107
TotalEnergies
TTE
$186B
| $830K | ﹤0.01% |
16,471
-16,408
| -50% | -$829K |
2016 Q1
4 quarters
|
|
|
MORE
4108
DELISTED
Monogram Residential Trust, Inc.
MORE
| $830K | ﹤0.01% |
83,273
-33,815
| -29% | -$345K |
2016 Q4
1 quarter
|
|
4109
Aecom
ACM
$7.5B
| $829K | ﹤0.01% |
23,296
-1,194,249
| -98% | -$43.7M |
2016 Q1
4 quarters
|
|
|
FPRX
4110
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $828K | ﹤0.01% |
22,900
+17,600
| +332% | +$776K |
2016 Q4
1 quarter
|
|
4111
John Hancock Multifactor Mid Cap ETF
JHMM
$5.93B
| $826K | ﹤0.01% |
+27,159
| New | +$813K |
2017 Q1
0 quarters
|
|
|
ZYNE
4112
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $826K | ﹤0.01% |
+41,100
| New | +$817K |
2017 Q1
0 quarters
|
|
|
AIRM
4113
PUT
DELISTED
Air Methods Corp
AIRM
| $826K | ﹤0.01% |
19,200
+7,800
| +68% | +$302K |
2013 Q2
15 quarters
|
|
4114
Iridium Communications
IRDM
$5.13B
| $825K | ﹤0.01% |
+85,502
| New | +$816K |
2017 Q1
0 quarters
|
|
4115
Paylocity
PCTY
$7.85B
| $825K | ﹤0.01% |
21,365
-196,410
| -90% | -$6.83M |
2016 Q4
1 quarter
|
|
|
WGL
4116
CALL
DELISTED
Wgl Holdings
WGL
| $825K | ﹤0.01% |
10,000
+4,700
| +89% | +$382K |
2016 Q4
1 quarter
|
|
|
CAVM
4117
PUT
DELISTED
Cavium, Inc.
CAVM
| $824K | ﹤0.01% |
11,500
+1,200
| +12% | +$80.3K |
2013 Q2
15 quarters
|
|
4118
CALL
Fomento Económico Mexicano
FMX
$39.9B
| $823K | ﹤0.01% |
9,300
+1,300
| +16% | +$106K |
2016 Q2
3 quarters
|
|
4119
PUT
Veeco
VECO
$3.27B
| $821K | ﹤0.01% |
+27,500
| New | +$766K |
2017 Q1
0 quarters
|
|
|
AIRM
4120
CALL
DELISTED
Air Methods Corp
AIRM
| $821K | ﹤0.01% |
19,100
-18,400
| -49% | -$711K |
2013 Q2
15 quarters
|
|
4121
CALL
TG Therapeutics
TGTX
$8.11B
| $820K | ﹤0.01% |
+70,400
| New | +$505K |
2017 Q1
0 quarters
|
|
4122
UFP Industries
UFPI
$4.22B
| $820K | ﹤0.01% |
+24,954
| New | +$834K |
2017 Q1
0 quarters
|
|
|
RSPP
4123
CALL
DELISTED
RSP Permian, Inc.
RSPP
| $820K | ﹤0.01% |
19,800
+200
| +1% | +$8.31K |
2016 Q3
2 quarters
|
|
4124
PUT
Cimpress
CMPR
$1.79B
| $819K | ﹤0.01% |
9,500
+3,100
| +48% | +$268K |
2013 Q2
15 quarters
|
|
|
NSR
4125
DELISTED
Neustar Inc
NSR
| $818K | ﹤0.01% |
24,661
-3,441
| -12% | -$114K |
2013 Q2
15 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.